Radiation-Induced Prevention of Erlotinib-Induced Skin Rash Is Transient: A New Aspect Toward the Understanding of Epidermal Growth Factor Receptor Inhibitor–Associated Cutaneous Adverse Effects-Reference-Cited by-同舟云学术

Radiation-Induced Prevention of Erlotinib-Induced Skin Rash Is Transient: A New Aspect Toward the Understanding of Epidermal Growth Factor Receptor Inhibitor–Associated Cutaneous Adverse Effects

Published:2007-10-10 Issue:29 Volume:25 Page:4697-4698
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Gerber Peter Arne¹,Enderlein Elaine¹,Homey Bernhard¹,Muller Anja²,Boelke Edwin²,Budach Wilfried²

Affiliation:

1. Department of Dermatology, Heinrich-Heine-University, Duesseldorf, Germany

2. Department of Radiation Oncology, Heinrich-Heine-University, Duesseldorf, Germany

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2007.12.8330

Reference6 articles.

1. Erlotinib Induced Skin Rash Spares Skin in Previous Radiotherapy Field

2. Temporal Dependence of the Effect of Radiation on Erlotinib-Induced Skin Rash

3. Mechanisms of cutaneous toxicities to EGFR inhibitors

4. Radiation dermatitis: Clinical presentation, pathophysiology, and treatment 2006

5. Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Schattenseiten der Targeted Therapy;hautnah dermatologie;2017-07

2. Kutane Nebenwirkungen zielgerichteter onkologischer Arzneimittel;Der Hautarzt;2016-11-24

3. Mechanisms underlying skin disorders induced by EGFR inhibitors;Molecular & Cellular Oncology;2015-06

4. Toxicité cutanée des anti-EGFR (epidermal growth factor receptor) : algorithme thérapeutique du groupe français PROCUR;Bulletin du Cancer;2013-05

5. Spared Pre-irradiated Area in Pustular Lesions Induced by Icotinib Showing Decreased Expressions of CD1a+ Langerhans Cells and FGFR2;Japanese Journal of Clinical Oncology;2012-12-21